Parexel’s Stacy Hurt draws on her experience with chemotherapy and as a caregiver to spot patient burdens that AI-assisted ...
Darwin Biotech ("Darwin"), a clinical-stage company developing treatments for neurological diseases, today announced that data from its randomized, double-blind, placebo-controlled Phase 1 study of ...
Corso identified inconsistent data standards across clinical research as a major obstacle. Unlike healthcare, which has made ...
Before asking whether AI can automate a clinical trial workflow, ask a more fundamental question: Why does this work exist in ...
Rheumatology clinical trials are adapting to changing patient populations, with implications for recruitment, trial design, and treatment evaluation.
Dublin, Oct. (GLOBE NEWSWIRE) -- "Cardiovascular Clinical Trials Market Size, Share & Trends Analysis Report by Phase, Study Design, Indication by Study Design, Indication, Service, Sponsor, Region, ...
Building flexibility into study design and using just-in-time supply models can help sponsors adapt to disruption, reduce ...
Bispecific programs differ by practice size, but shared core components can guide adaptation, experts said at a webinar for ...
Base Case U.S. Market Opportunity Estimated at 15,000 Patients, With Potential to Expand to Approximately 30,000 Patients -- ...
Vera Clinic Academy reports preliminary graft retention findings from its patient analysis, with no repeat surgical ...
Dimerix, Lumos Diagnostics, TrivarX and Optiscan have posted September 2026 quarterly results with progress made across key ...
InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the first subject has been dosed in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results